Scans rationed after facility shuts down
NSW nuclear medicine plant halts production of a radioisotope used in about 80% of scans
![nuclear medicine](https://www.ausdoc.com.au/wp-content/uploads/2022/08/nuclear_medicine_ansto_facility_photo_ansto-1.jpg)
Less than two weeks ago, it shut down production of the radioisotope molybdenum-99 (Mo-99), the parent isotope of technetium-99m, which is used in about 80% of nuclear scans.
“We have four teams working in parallel to progress options to rectify the issue, and a fifth in daily contact with international partners to source medicine from overseas,” an ANSTO spokesperson said.